Stockscreener 앱 받기
0.6265
0.98%
-0.0062
시간 외 거래:
.60
-0.0265
-4.23%
전일 마감가:
$0.6327
열려 있는:
$0.6362
하루 거래량:
5.00M
Relative Volume:
2.53
시가총액:
$5.71M
수익:
-
순이익/손실:
$-14.07M
주가수익비율:
-0.0448
EPS:
-13.99
순현금흐름:
$-12.56M
1주 성능:
-7.30%
1개월 성능:
-38.58%
6개월 성능:
-23.92%
1년 성능:
-82.93%
1일 변동 폭
$0.593
$0.6628
1주일 범위
$0.593
$0.6844
52주 변동 폭
$0.593
$4.318
Palisade Bio Inc Stock (PALI) Company Profile
명칭
Palisade Bio Inc
전화
(858) 704-4900
주소
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
PALI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
0.6265 | 5.90M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Palisade Bio Inc 주식(PALI)의 최신 뉴스
Is Palisade Bio Inc. meeting your algorithmic filter criteriaEarnings Summary Report & Accurate Entry/Exit Alerts - Newser
Palisade Bio Receives Health Canada Clearance for Phase 1b - GlobeNewswire
Palisade Bio launches phantom equity plan and updates executive contracts By Investing.com - Investing.com Canada
Analyzing drawdowns of Palisade Bio Inc. with statistical toolsQuarterly Portfolio Report & Reliable Price Breakout Alerts - Newser
Relative strength of Palisade Bio Inc. in sector analysisJuly 2025 PostEarnings & Community Verified Trade Signals - Newser
Palisade Bio receives Health Canada clearance for FSCD drug trial By Investing.com - Investing.com South Africa
Palisade Bio Launches Phantom Unit Plan for Employees - TipRanks
Palisade Bio receives Health Canada clearance for FSCD drug trial - Investing.com
Palisade Bio launches phantom equity plan and updates executive contracts - Investing.com
Palisade Bio Says Health Canada Gave Clearance to Start Phase 1b Trial of PALI-2108 - MarketScreener
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
First-Ever Dual Anti-Inflammatory & Anti-Fibrotic Drug: Palisade Bio's PALI-2108 Cleared for Crohn's Trial - Stock Titan
Price momentum metrics for Palisade Bio Inc. explained2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser
Using data models to predict Palisade Bio Inc. stock movementMarket Activity Summary & Free High Return Stock Watch Alerts - Newser
Using data tools to time your Palisade Bio Inc. exitMarket Trend Summary & Smart Allocation Stock Tips - Newser
What is the Moat Score of Palisade Bio Inc.Stop Loss & Advanced Technical Signal Analysis - خودرو بانک
Palisade Bio Inc. stock volume spike explainedEarnings Overview Summary & AI Powered Buy/Sell Recommendations - Newser
Quantitative breakdown of Palisade Bio Inc. recent moveLayoff News & Real-Time Volume Surge Alerts - Newser
Using Python tools to backtest Palisade Bio Inc. strategiesCPI Data & Fast Gaining Stock Strategy Reports - Newser
Historical volatility pattern of Palisade Bio Inc. visualized2025 Fundamental Recap & Low Risk Growth Stock Ideas - Newser
How to build a dashboard for Palisade Bio Inc. stockJuly 2025 Selloffs & Weekly Momentum Picks - Newser
Is Palisade Bio Inc. stock poised for growth2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
Sentiment analysis tools applied to Palisade Bio IncWatch List & Safe Entry Point Identification - Newser
Is Palisade Bio Inc. trending in predictive chart modelsWeekly Profit Report & Safe Capital Growth Stock Tips - Newser
Is Palisade Bio Inc. building a consolidation baseMarket Trend Report & Fast Entry Momentum Alerts - Newser
Volatility clustering patterns for Palisade Bio Inc.Quarterly Market Summary & Daily Price Action Insights - Newser
Real time scanner hits for Palisade Bio Inc. explainedMarket Risk Analysis & Real-Time Stock Entry Alerts - Newser
Sentiment analysis tools applied to Palisade Bio Inc.July 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
Multi factor analysis applied to Palisade Bio Inc.2025 Technical Patterns & Expert Approved Momentum Ideas - Newser
Predicting Palisade Bio Inc. trend using moving averagesJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - Newser
Has Palisade Bio Inc. found a price floorBull Run & Fast Exit/Entry Strategy Plans - Newser
Exit strategy if you’re trapped in Palisade Bio Inc.2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
When is the best time to exit Palisade Bio Inc.July 2025 Catalysts & Smart Swing Trading Alerts - Newser
Applying Wyckoff theory to Palisade Bio Inc. stockTrend Reversal & AI Forecast Swing Trade Picks - Newser
Tools to assess Palisade Bio Inc.’s risk profileWeekly Volume Report & Daily Profit Focused Screening - Newser
Growth Review: What is the Moat Score of Palisade Bio Inc.Trade Volume Summary & Long-Term Safe Investment Ideas - خودرو بانک
Palisade Bio Inc (PALI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):